PFO
KNTE

Pathstone Family Office’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Pathstone Family Office’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-198
Closed -$8K – 1382
2020
Q4 		$8K Buy
+198
New +$8K ﹤0.01% 901